The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrated whole-exome and transcriptome analysis of 250 treatment-refractory or relapsed (R/R) childhood solid tumors.
 
Sara A. Byron
No Relationships to Disclose
 
William P. D. Hendricks
Leadership - Vidium Animal Health
 
Abhinav B. Nagulapally
No Relationships to Disclose
 
Karl Dykema
No Relationships to Disclose
 
Jeffrey Bond
Employment - Illumina (I)
Stock and Other Ownership Interests - Illumina (I)
 
Hsien-Chao Chou
No Relationships to Disclose
 
Jun S. Wei
No Relationships to Disclose
 
Xinyu Wen
No Relationships to Disclose
 
Hue V. Reardon
No Relationships to Disclose
 
Sara Nasser
No Relationships to Disclose
 
Tyler Izatt
No Relationships to Disclose
 
Daniel Enriquez
No Relationships to Disclose
 
Apurva M. Hegde
No Relationships to Disclose
 
Szabolcs Szelinger
No Relationships to Disclose
 
Jonathan J. Keats
Consulting or Advisory Role - GNS Healthcare
Research Funding - Amgen; Janssen
 
Rebecca F. Halperin
Employment - Sema4
 
Javed Khan
Research Funding - Lentigen (Inst); Taiho Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Monoclonal antibody-based therapeutics targeting fibroblast growth factor receptor 4 (FGFR4) for potential treatment of human cancers expressing FGFR4
 
Giselle Linda Saulnier Sholler
Honoraria - YmAbs Therapeutics Inc
Consulting or Advisory Role - California Cryobank
 
Jeffrey M. Trent
No Relationships to Disclose